scholarly article | Q13442814 |
P356 | DOI | 10.1021/JM00378A040 |
P698 | PubMed publication ID | 6502607 |
P2093 | author name string | J R Sorenson | |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | copper | Q753 |
P304 | page(s) | 1747-1749 | |
P577 | publication date | 1984-12-01 | |
P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
P1476 | title | Bis(3,5-diisopropylsalicylato)copper(II), a potent radioprotectant with superoxide dismutase mimetic activity | |
P478 | volume | 27 |
Q44611932 | Agents capable of eliminating reactive oxygen species. Catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis |
Q44624611 | Amelioration of radiation-induced oxidative stress and biochemical alteration by SOD model compounds in pre-treated γ-irradiated rats |
Q71667088 | Antiradiation compounds. 24. Stability of copper (II) complexes of bis(methylthio) and methylthio amino derivatives of 1-methylpyridinium- and 1-methylquinolinium-2-dithioacetic acids in the presence of amino acids, simple peptides, and a protein |
Q73103061 | Copper(II) complexes of a nonsteroidal anti-inflammatory drug niflumic acid. Synthesis, crystal structure of tetrakis-mu-(2-[3-(trifluoromethyl) phenyl]aminonicotinato)bis(dimethylsulfoxide)-dicopper(II) complex at 190 K. Anti-inflammatory propertie |
Q26750933 | Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review |
Q36191166 | Dose Optimization Study of AEOL 10150 as a Mitigator of Radiation-Induced Lung Injury in CBA/J Mice |
Q36711411 | Drug antioxidant effects. A basis for drug selection? |
Q43019211 | Effects of paraquat on the green alga Dunaliella salina: protection by the mimic of superoxide dismutase, Desferal-Mn(IV). |
Q68495362 | Effects of some non-steroidal anti-inflammatory drug copper complexes on polymorphonuclear leukocyte oxidative metabolism |
Q41840738 | Glutathione transferase mimics: micellar catalysis of an enzymic reaction |
Search more.